Sens. Bill Cassidy (R-LA), Michael Bennet (D-CO), Chuck Grassley (R-IA), Tom Carper (D-DE), Todd Young (R-IN) and Claire McCaskill (D-MO) are seeking guidance from health care stakeholders as they develop legislation to improve price transparency in the health care market and lower costs. In a letter yesterday to health care, patient and business groups, including the AHA, the senators request feedback by March 23 on questions ranging from what consumer price and quality information is or should be available, who should be responsible for providing and sharing price information, and how to avoid creating unnecessary or additional burdens. The senators plan to host roundtable conversations with a variety of experts in the coming weeks, and are also engaging the administration, members of Congress and governors. AHA plans to submit comments.

Related News Articles

Headline
The Centers for Medicare…
Perspective
Last week, I shared a few areas where we can advance health in America this year, even in a divided Congress.
Headline
To encourage drug companies to seek approval for over-the-counter versions of naloxone, an emergency treatment for opioid overdose, the Food and Drug…
Headline
Patients in the most rural counties had an 87 percent greater chance of receiving an opioid prescription from their primary care provider between January 2014…
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Headline
AHA said it generally supports CMS’ efforts to grant greater state-level flexibility and reduce regulatory burden, but urged the agency to ensure Medicaid…